These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 2354287)
41. Recent spread of human T lymphotropic virus type II among injecting drug users in Spain. HTLV Spanish Study Group. Soriano V; Gutiérrez M; Merino F; Dronda F; Esparza B; Tuset C J Infect Dis; 1996 Oct; 174(4):891-3. PubMed ID: 8843239 [No Abstract] [Full Text] [Related]
42. No proof of HTLV-I/II in intravenous drug abusers with a high rate of HIV-1 infection in central Thailand. Saguanwongse S; Muangpom A; Ruchusatsawat N; Wongcheree S; Warachit P; Miyamura K; Yamazaki S; Honda M Microbiol Immunol; 1996; 40(9):639-44. PubMed ID: 8908608 [TBL] [Abstract][Full Text] [Related]
43. HTLV-II among injecting drug users in Stockholm. Krook A; Blomberg J Scand J Infect Dis; 1994; 26(2):129-32. PubMed ID: 8036466 [TBL] [Abstract][Full Text] [Related]
44. Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users. Hartgers C; van Ameijden EJ; van den Hoek JA; Coutinho RA Public Health Rep; 1992; 107(6):675-81. PubMed ID: 1454980 [TBL] [Abstract][Full Text] [Related]
46. HTLV-1 has reached Thailand via a heterosexual route. Hemachudha T; Niruthisard S; Sirivichayakul S; Chomchey P; Wilde H Trans R Soc Trop Med Hyg; 1992; 86(4):434. PubMed ID: 1440828 [No Abstract] [Full Text] [Related]
47. The effects of breastfeeding and presence of antibody to p40tax protein of human T cell lymphotropic virus type-I on mother to child transmission. Hirata M; Hayashi J; Noguchi A; Nakashima K; Kajiyama W; Kashiwagi S; Sawada T Int J Epidemiol; 1992 Oct; 21(5):989-94. PubMed ID: 1468864 [TBL] [Abstract][Full Text] [Related]
48. The emerging role of HTLV-I/II and HIV-1 among intravenous drug users in Detroit. Ognjan AF; Lewandowski CA; Belian BT; Burczak J; Markowitz N; Lee H; Saravolatz LD Henry Ford Hosp Med J; 1992; 40(1-2):131-5. PubMed ID: 1428966 [TBL] [Abstract][Full Text] [Related]
49. Does bleach disinfection of syringes protect against hepatitis C infection among young adult injection drug users? Kapadia F; Vlahov D; Des Jarlais DC; Strathdee SA; Ouellet L; Kerndt P; Morse E EV; Williams I; Garfein RS; Epidemiology; 2002 Nov; 13(6):738-41. PubMed ID: 12410020 [TBL] [Abstract][Full Text] [Related]
50. A historical study of human T lymphotropic virus type I transmission in Barbados. Riedel DA; Evans AS; Saxinger C; Blattner WA J Infect Dis; 1989 Apr; 159(4):603-9. PubMed ID: 2538516 [TBL] [Abstract][Full Text] [Related]
51. Absence of human T cell lymphotrophic virus (HTLV) type I and II DNA in French anti-HTLV-I/II-negative intravenous drug users. Lefrère F; Wattel E; Mariotti M; Agis F; Gordien E; Lefrère JJ J Infect Dis; 1992 Jul; 166(1):212-3. PubMed ID: 1607702 [No Abstract] [Full Text] [Related]
52. HTLV-II among Italian intravenous drug users and hemophiliacs. Zanetti AR; Zehender G; Tanzi E; Galli C; Rezza G; Cargnel A; Boschini A; Mari D; Pizzocolo G; Mazzotta F Eur J Epidemiol; 1992 Sep; 8(5):702-7. PubMed ID: 1426170 [TBL] [Abstract][Full Text] [Related]
53. Lack of virus transmission to offspring from a gorilla positive for HTLV-I-related antibodies and provirus. Srivastava BI; Prowten AW Am J Vet Res; 1989 Jul; 50(7):1188. PubMed ID: 2774342 [No Abstract] [Full Text] [Related]
54. Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, U.S.A. Vlahov D; Khabbaz RF; Cohn S; Galai N; Taylor E; Kaplan JE J Acquir Immune Defic Syndr Hum Retrovirol; 1995 May; 9(1):89-96. PubMed ID: 7712239 [TBL] [Abstract][Full Text] [Related]
55. Marriage patterns among HTLV-I seropositive women in Japan. Umemoto M; Take H; Kusuhara K; Kuraya K Cancer Lett; 1994 Jun; 81(2):237-40. PubMed ID: 8012942 [TBL] [Abstract][Full Text] [Related]
57. [Relatively low HIV prevalence among drug users in The Hague in spite of risky injection behavior]. de Haan HA; van den Hoek JA; van Haastrecht HJ; van der Meer CW; Coutinho RA Ned Tijdschr Geneeskd; 1991 Feb; 135(6):218-21. PubMed ID: 2005985 [TBL] [Abstract][Full Text] [Related]
58. Prevalence and epidemiologic correlates of human T cell lymphotropic virus infection among intravenous drug users. Schwebke J; Calsyn D; Shriver K; Saxon A; Kleyn J; Oluoch-Mitchell E; Olmstead L; Fisher LD; Krone M; Ashley R J Infect Dis; 1994 May; 169(5):962-7. PubMed ID: 8169427 [TBL] [Abstract][Full Text] [Related]
59. Incidence of human T lymphotropic virus type I seroconversion after age 40 among Japanese residents in an area where the virus is endemic. Takezaki T; Tajima K; Komoda H; Imai J J Infect Dis; 1995 Mar; 171(3):559-65. PubMed ID: 7876601 [TBL] [Abstract][Full Text] [Related]
60. Experimental transmission of HTLV-I into C3H/HeJ mice. Ohsugi T; Chinami M; Yuge K; Hachiya N; Shingu M Kurume Med J; 1993; 40(2):89-91. PubMed ID: 8231068 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]